Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Instituto Alexander Fleming is a leading private oncology center in Argentina, recognized for its advanced technology and multidisciplinary team. It was the first institution in Latin America accredited by the U.S. National Marrow Donor Program for unrelated bone marrow transplants. The institute provides comprehensive cancer care, including diagnosis, treatment, intensive care for cancer patients, and educational activities affiliated with the University of Buenos Aires Faculty of Medicine.
No clinical trial results or drug development programs are reported; its focus is on patient care and medical education.
It has over two decades of experience as a reference center in oncology in Latin America.
The institute also participates in international collaborative studies and scientific meetings.
Employee estimates range from about 350 to over 500 staff members.
Revenue estimated at $51.4 million USD annually.
Founded March/April of 1994.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Alexander Fleming.